{"result": {"id": "27a16f24-638e-4990-831b-f4f4b83213fd", "choices": [{"finish_reason": "stop", "index": 0, "logprobs": null, "message": {"content": "**Mineralocorticoid Receptor Antagonists (MRA)** are a class of non-steroidal medications that act as selective antagonists of the mineralocorticoid receptor (MR), with high affinity and specificity for MR and low affinity for androgen, glucocorticoid, progesterone, and estrogen receptors, thereby minimizing adverse effects. MRAs are primarily used to treat **primary aldosteronism**, where they serve as a first-line therapy, as well as **heart failure** (particularly **HFrEF**), where they improve prognosis, reduce hospitalization rates, and lower mortality. Additionally, MRAs are employed in the management of **chronic kidney disease (CKD)** and **diabetic kidney disease**, where they help reduce proteinuria and slow disease progression.  \n\nMRAs are also utilized in **resistant hypertension**, often in combination with other antihypertensive agents, to effectively lower blood pressure. However, their use may be associated with side effects such as **hyperkalemia** (especially in CKD patients), **male gynecomastia**, and **sexual dysfunction**. Newer MRAs, such as **finerenone**, have been developed specifically for treating diabetic kidney disease, offering targeted therapeutic benefits.  \n\nOverall, MRAs are versatile medications with significant clinical applications in cardiovascular, renal, and endocrine disorders, though careful monitoring is required to mitigate potential adverse effects.", "refusal": null, "role": "assistant", "annotations": null, "audio": null, "function_call": null, "tool_calls": null}}], "created": 1751559481, "model": "deepseek-chat", "object": "chat.completion", "service_tier": null, "system_fingerprint": "fp_8802369eaa_prod0623_fp8_kvcache", "usage": {"completion_tokens": 274, "prompt_tokens": 381, "total_tokens": 655, "completion_tokens_details": null, "prompt_tokens_details": {"audio_tokens": null, "cached_tokens": 64}, "prompt_cache_hit_tokens": 64, "prompt_cache_miss_tokens": 317}}, "input": {"messages": [{"content": "\nYou are a helpful assistant responsible for generating a comprehensive summary of the data provided below.\nGiven one or two entities, and a list of descriptions, all related to the same entity or group of entities.\nPlease concatenate all of these into a single, comprehensive description. Make sure to include information collected from all the descriptions.\nIf the provided descriptions are contradictory, please resolve the contradictions and provide a single, coherent summary.\nMake sure it is written in third person, and include the entity names so we have the full context.\n\n#######\n-Data-\nEntities: \"MRA\"\nDescription List: [\"MRA is a non-steroidal mineralocorticoid receptor antagonist used for treating primary aldosteronism, heart failure, and chronic kidney disease (CKD). It has high selectivity and affinity for the mineralocorticoid receptor (MR) and low affinity for androgen, glucocorticoid, progesterone, and estrogen receptors, reducing adverse events.\", \"MRA is a type of medication recommended for HFrEF patients to improve prognosis and reduce hospitalization rates and mortality\", \"MRA is a type of medication used for treating conditions like primary aldosteronism, with potential side effects such as male gynecomastia and sexual dysfunction\\\"\", \"MRA（盐皮质激素受体拮抗剂）用于难治性高血压治疗，常与其他降压药联用\\\"\", \"Mineralocorticoid Receptor Antagonists (MRA) are medications that can lower blood pressure and reduce proteinuria, but may cause hyperkalemia in some CKD patients\", \"Mineralocorticoid Receptor Antagonists (MRA) are used as first-line treatment for primary aldosteronism\", \"Mineralocorticoid Receptor Antagonists are used in heart failure management\\\"\", \"Mineralocorticoid receptor antagonists, including finerenone, used to treat diabetic kidney disease\\\"\"]\n#######\nOutput:\n", "role": "user"}], "parameters": {"model": "deepseek-chat", "frequency_penalty": 0.0, "max_tokens": 500, "n": 1, "presence_penalty": 0.0, "temperature": 0.0, "top_p": 1.0}}, "key": "chat_summarize_75c24b1d22a13900583ecae391c9bad0250910e8945040533d84882a51c9e8fe_v2"}